Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...

According to a recent KPMG report, the global M&A landscape in 2024 signals a rebound despite challenges like geopolitical tensions, high ...

About two and a half years before they sealed a $3.3 billion deal, Bain Capital and its life sciences team started courting ...

Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.